Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Opendoor Technologies Inc (OPEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Opendoor Technologies Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.03 (market cap $3.94B), while Opendoor Technologies Inc trades at $1.98 (market cap $2.05B). The key difference: Edgewise Therapeutics Inc. Common Stock is the larger of the two by market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Opendoor Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Opendoor Technologies Inc for 33 Days on average.
| EWTX | OPEN | |
|---|---|---|
Market Cap | $3.94B | $2.05B |
Volume | 810,104 | 27,619,294 |
Sector | Health | Real Estate |
52-Week High | $48.35 | $9.37 |
52-Week Low | $14.89 | $1.99 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $3.48B | $3.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Opendoor (OPEN) trades at $1.99, down 4.78% on the day, reflecting persistent bearish sentiment amid a challenging housing market. The stock shows oversold technical signals with an RSI near 21, while fundamentals reveal steep losses with a net income margin of -46.74% in 2025 and negative ROE of -196.89%. Recent news highlights expansion into mortgages across 35-40 states by end-2026 to drive growth, but earnings misses in Q1 and Q2 2026 underscore execution risks. Cash flow improved in 2025 with net positive $538M, yet 2026 projections show renewed outflows.
The outlook remains cautious; analyst consensus is mixed with 65% hold ratings, but a $4.92 price target implies significant upside if turnaround succeeds. Key risks include interest rate sensitivity, high debt levels, and prolonged profitability challenges. Revenue declines from $15.6B in 2022 to $4.4B in 2025 highlight operational headwinds, making recovery dependent on housing market stabilization and cost controls.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →
